---
layout: post
title: "Homeopathic Drug Products; Guidance for Food and Drug Administration Staff and Industry; Availability"
date: 2026-02-05 19:01:47 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2022-26567
original_published: 2022-12-07 00:00:00 +0000
significance: 8.00
---

# Homeopathic Drug Products; Guidance for Food and Drug Administration Staff and Industry; Availability

**Published:** February 05, 2026 19:01 UTC
**Source:** Federal Register
**Original Published:** December 07, 2022 00:00 UTC
**Document Number:** 2022-26567

## Summary

The Food and Drug Administration (FDA, Agency, or we) is announcing the availability of a final guidance for FDA staff and industry entitled "Homeopathic Drug Products." The guidance describes how FDA intends to prioritize enforcement and regulatory action with regard to drug products, including biological products, labeled as homeopathic and marketed in the United States without the required FDA approval.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2022/12/07/2022-26567/homeopathic-drug-products-guidance-for-food-and-drug-administration-staff-and-industry-availability)
- API: https://www.federalregister.gov/api/v1/documents/2022-26567

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
